Gerresheimer (GXI) Given a €87.70 Price Target at JPMorgan Chase & Co.

JPMorgan Chase & Co. set a €87.70 ($104.40) target price on Gerresheimer (ETR:GXI) in a research report released on Thursday. The firm currently has a buy rating on the stock.

Other equities research analysts have also issued reports about the stock. Commerzbank set a €77.00 ($91.67) price objective on shares of Gerresheimer and gave the stock a buy rating in a research report on Thursday, September 28th. Berenberg Bank set a €75.00 ($89.29) price objective on shares of Gerresheimer and gave the stock a buy rating in a research report on Wednesday, October 11th. Credit Suisse Group set a €80.00 ($95.24) price objective on shares of Gerresheimer and gave the stock a buy rating in a research report on Tuesday, October 10th. set a €65.00 ($77.38) target price on shares of Gerresheimer and gave the company a neutral rating in a report on Tuesday, October 17th. Finally, Deutsche Bank set a €64.00 ($76.19) target price on shares of Gerresheimer and gave the company a neutral rating in a report on Thursday, October 12th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the company’s stock. Gerresheimer currently has an average rating of Hold and a consensus price target of €71.47 ($85.08).

Gerresheimer (GXI) traded up €0.80 ($0.95) during trading on Thursday, reaching €72.05 ($85.77). 166,281 shares of the company traded hands, compared to its average volume of 107,411. Gerresheimer has a 52-week low of €59.97 ($71.39) and a 52-week high of €78.25 ($93.15). The firm has a market capitalization of $2,260.00 and a PE ratio of 51.10.

ILLEGAL ACTIVITY WARNING: “Gerresheimer (GXI) Given a €87.70 Price Target at JPMorgan Chase & Co.” was posted by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://www.chaffeybreeze.com/2018/01/05/gerresheimer-gxi-given-a-87-70-price-target-at-jpmorgan-chase-co.html.

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, such as inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply